ALYSSA ROSEN: Open Payments
NPI 1336285261 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$12,233 in 23 payments from 7 companies in 2025. Trend: 2023 $53,912 · 2024 $59,770 · 2025 $12,233
Honoraria: $9,350Consulting: $1,380Travel & lodging: $782Food & beverage: $721
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 15 | $10,643 |
| E.R. Squibb & Sons, L.L.C. | 3 | $1,489 |
| Alkermes, Inc. | 1 | $27 |
| Supernus Pharmaceuticals, Inc. | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Lundbeck LLC | 1 | $18 |
| ABBVIE INC. | 1 | $15 |
Products named: Auvelity, COBENFY, REXULTI, ARISTADA, Qelbree, VRAYLAR.
Industry payments across CA — which companies pay providers there.
